ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow RMD
ResMed Inc. (RMD) Dividend Safety Score
ResMed Inc.'s stockrow Dividend Safety Score is 96 out of 100, based on payout ratios, leverage, dividend streak and earnings stability for fiscal 2026.
Dividend Safety Score, annual
Embed this chart
Annual newest first
| Period | Dividend Safety Score | Change (points) |
|---|---|---|
| FY2026 | 96 | — |
How fiscal 2026’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Payout of earnings | 22.95% | — | Pass | 25 |
| Payout of free cash flow | 21.47% | — | Pass | 25 |
| Net debt / EBITDA net cash | — | — | Pass | 20 |
| Years without a dividend cut | 10 | — | Pass | 16 |
| Years of falling or negative earnings over the last 10 fiscal years | 0 | — | Pass | 10 |
| Dividend Safety Score | Well covered | 96 | ||
How the stockrow Dividend Safety Score works
Our own composite, out of 100, for the latest fiscal year: up to 25 points for how little of its earnings the dividend takes, 25 for how little of its free cash flow, 20 for net debt against EBITDA, 20 for the years it has paid without a cut and 10 for how steady earnings per share have been over ten years. How we calculate it.
| 80–100 | Well covered |
|---|---|
| 60–79 | Adequately covered |
| 40–59 | Stretched |
| below 40 | Weakly covered |
Not worked out for a company that pays no regular dividend, for banks and REITs, whose payouts and leverage these measures do not describe, or with fewer than five years of earnings.
Dividend Safety Score against peers
| Company | Dividend Safety Score |
|---|---|
| WST West Pharmaceutical Services, Inc. compare | 100 |
| RMD ResMed Inc. | 96 |
| BDX Becton, Dickinson and Company compare | 67 |
| ALC Alcon compare | 66 |
| BAX Baxter International Inc. compare | 0 |
| RGEN Repligen Corporation compare | — |
| SOLV Solventum Corporation compare | — |
| COO The Cooper Companies, Inc. compare | — |
| MDLN Medline Inc. compare | — |
What Dividend Safety Score is
The stockrow Dividend Safety Score rates how well earnings and free cash flow cover the dividend, with leverage, the dividend’s record and stable earnings.
Up to 25 points for the payout of earnings, 25 for the payout of free cash flow, 20 for net debt ÷ EBITDA, 20 for the years without a dividend cut and 10 for stable earnings
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement